Drug Trial Radar · NCT07639021
A Research Study Comparing Different Ways of Increasing the Dose of NNC0662-0419 in Participants With Obesity
Last checked: Nov 20, 2026Latest source record: Sep 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
233
Actual
Start
Jun 9, 2026
Primary completion
Jun 14, 2027
Study completion Jun 14, 2027
Sponsor
- Lead sponsor
- Novo Nordisk A/SNovo Nordisk (NVO)
- Sponsor type
- Industry
- First posted
- Jun 10, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of the study is to find out if NNC0662-0419 is safe and effective for treating participants living with obesity.
Conditions
- Obesity
Interventions
NNC0662-0419Drug
NNC0662-0419 will be administered subcutaneously.
SemaglutideDrug
Semaglutide will be administered subcutaneously.
NNC0662-0419 PlaceboDrug
Placebo matched to NNC0662-0419 will be administered subcutaneously.
Semaglutide placeboDrug
Placebo matched to semaglutide will be administered subcutaneously.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of gastrointestinal adverse eventsTime frame: From week 0 to week 39
Locations
25 sites in 2 countries. Site status is shown where the registry gives one.
Chambliss Clinical Trials, LLC
Montgomery, Alabama
FDRC
Costa Mesa, California
Los Angeles Institute for Metabolic Research
Los Angeles, California
Encore Medical Research LLC
Hollywood, Florida
South Broward Research LLC
Miramar, Florida
West Orange Endocrinology
Ocoee, Florida
Cedar-Crosse Research Center
Chicago, Illinois
Great Lakes Clinical Trials
Chicago, Illinois
Midwest Inst For Clin Res
Indianapolis, Indiana
L-MARC Research Center
Louisville, Kentucky
Endo And Metab Cons
Rockville, Maryland
StudyMetrix Research LLC
City of Saint Peters, Missouri
Great Lakes Medical Research
Westfield, New York
KDCILM, LLC & Accellacare US, Inc.
Wilmington, North Carolina
Family Practice Center of Wadsworth Inc.
Wadsworth, Ohio
UPA Ctr Weight and Eating Dis
Philadelphia, Pennsylvania
Clinical Res Collaborative
Cumberland, Rhode Island
Holston Medical Group_Bristol
Bristol, Tennessee
Holston Medical Group
Kingsport, Tennessee
Clinical Research Associates
Nashville, Tennessee
PlanIt Research, PLLC
Houston, Texas
Pinnacle Clinical Research
San Antonio, Texas
National Clin Res Inc.
Richmond, Virginia
Rainier Clin Res Ctr Inc
Renton, Washington
Isis Clinical Res. Ctr P.S.C.
Guaynabo, Puerto Rico
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.